Literature DB >> 12418722

Betaine reduces the irritating effect of sodium lauryl sulfate on human oral mucosa in vivo.

Irma Rantanen1, Ingrid Nicander, Kirsti Jutila, Stig Ollmar, Jorma Tenovuo, Eva Söderling.   

Abstract

Our aim was to evaluate whether betaine has a protective effect during exposure of the human oral mucosa in vivo to sodium lauryl sulfate (SLS) or cocoamidopropylbetaine (CAPB) as measured with a multifrequency electrical impedance spectrometer (EI). Both detergents were used at the concentration of 2.0% w/v with and without 4.0% w/v betaine in distilled water in 20 volunteers, and 0.5% and 1.0% w/v SLS combined with 4.0% w/v betaine in 5 volunteers. EI measurements were taken before application of the test solutions, after their removal, and every 15 min up to 45 min. Both 0.5% and 1% SLS solutions showed a significant reduction in 3 of the 4 indices, indicating mucosal irritation after the 15-min exposure (P < 0.05), whereas 2% SLS did so in all 4 indices (P < 0.001). Betaine had no effect on the detergent-induced decline with either the 2% or the 0.5% SLS solutions. However, when combined with the 1% SLS solution, betaine significantly (P < 0.05) reduced mucosal irritation by abolishing decreases in indices MIX (magnitude index) and IMIX (imaginary part index) and lowering it for PIX (phase index). The 2% CAPB solution showed a significant (P < 0.05) reduction in all 4 indices after the 15-min exposure, but the effect was significantly weaker than that of 2% SLS (P < 0.05). Betaine did not reduce the irritating effect of 2% CAPB. These findings can be used in the development of less irritating products for oral health care.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12418722     DOI: 10.1080/00016350260248292

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  1 in total

1.  Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia.

Authors:  Margarita Martín; Alicia Marín; Mario López; Olga Liñán; Felipe Alvarenga; David Büchser; Laura Cerezo
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.